Cross Country Healthcare (CCRN) Downgraded to “C+” at TheStreet

Cross Country Healthcare (NASDAQ:CCRN) was downgraded by equities research analysts at TheStreet from a “b” rating to a “c+” rating in a report issued on Monday, April 9th.

A number of other brokerages have also issued reports on CCRN. Jefferies Group started coverage on shares of Cross Country Healthcare in a report on Thursday, February 1st. They issued a “hold” rating and a $15.00 price target on the stock. BidaskClub raised shares of Cross Country Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, April 7th. Cantor Fitzgerald lowered shares of Cross Country Healthcare from an “overweight” rating to a “neutral” rating in a report on Friday, March 2nd. Zacks Investment Research lowered shares of Cross Country Healthcare from a “hold” rating to a “sell” rating in a research note on Wednesday, January 17th. Finally, Benchmark lowered shares of Cross Country Healthcare from a “buy” rating to a “hold” rating and set a $19.00 target price on the stock. in a research note on Thursday, March 1st. Two analysts have rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $15.13.

How to Become a New Pot Stock Millionaire

Shares of Cross Country Healthcare stock opened at $12.17 on Monday. The firm has a market capitalization of $436.77, a price-to-earnings ratio of 19.80, a PEG ratio of 2.15 and a beta of 0.91. Cross Country Healthcare has a 12-month low of $9.07 and a 12-month high of $15.09. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.21 and a current ratio of 2.21.

Cross Country Healthcare (NASDAQ:CCRN) last announced its quarterly earnings results on Wednesday, February 28th. The business services provider reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.02). The firm had revenue of $219.67 million during the quarter, compared to the consensus estimate of $225.60 million. Cross Country Healthcare had a return on equity of 10.24% and a net margin of 4.34%. Cross Country Healthcare’s revenue was down 1.3% on a year-over-year basis. During the same period last year, the business earned $0.20 EPS. research analysts expect that Cross Country Healthcare will post 0.5 earnings per share for the current fiscal year.

In related news, Director W Larry Cash bought 5,000 shares of the business’s stock in a transaction dated Monday, March 5th. The shares were purchased at an average price of $11.23 per share, with a total value of $56,150.00. Following the purchase, the director now owns 113,580 shares of the company’s stock, valued at approximately $1,275,503.40. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO William J. Grubbs acquired 10,000 shares of the company’s stock in a transaction that occurred on Monday, March 5th. The shares were acquired at an average cost of $11.18 per share, for a total transaction of $111,800.00. Following the purchase, the chief executive officer now directly owns 353,741 shares of the company’s stock, valued at $3,954,824.38. The disclosure for this purchase can be found here. Insiders own 3.40% of the company’s stock.

Large investors have recently bought and sold shares of the stock. Systematic Financial Management LP boosted its stake in Cross Country Healthcare by 86.9% during the fourth quarter. Systematic Financial Management LP now owns 188,282 shares of the business services provider’s stock worth $2,402,000 after acquiring an additional 87,557 shares in the last quarter. Teacher Retirement System of Texas bought a new stake in Cross Country Healthcare during the fourth quarter worth about $162,000. Highbridge Capital Management LLC bought a new stake in Cross Country Healthcare during the third quarter worth about $402,000. Royce & Associates LP boosted its stake in Cross Country Healthcare by 12.2% during the fourth quarter. Royce & Associates LP now owns 962,381 shares of the business services provider’s stock worth $12,280,000 after acquiring an additional 104,706 shares in the last quarter. Finally, Rhumbline Advisers boosted its stake in Cross Country Healthcare by 17.6% during the fourth quarter. Rhumbline Advisers now owns 84,226 shares of the business services provider’s stock worth $1,075,000 after acquiring an additional 12,621 shares in the last quarter. 95.19% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “Cross Country Healthcare (CCRN) Downgraded to “C+” at TheStreet” was first reported by Macon Daily and is owned by of Macon Daily. If you are reading this report on another publication, it was stolen and reposted in violation of US and international copyright & trademark laws. The original version of this report can be viewed at https://macondaily.com/2018/04/20/cross-country-healthcare-ccrn-rating-lowered-to-c-at-thestreet-updated.html.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc provides healthcare staffing, recruiting, and workforce solutions in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments.

Analyst Recommendations for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply